Skip to main content

Table 4 Clinical laboratory evaluations

From: Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression

 

Baseline

End of treatment

Change from baseline

 

Quetiapine XR

Quetiapine XR

Quetiapine XR

 

Mean (SD)

Mean (SD)

Mean (SD)

Body weight (kg)

63.15 (13.71)

64.26 (13.67)

1.02 (3.99)

Blood glucose (mg/dL)

98.5 (14.2)

100.3 (16.4)

2.1 (18.4)

HbA1c (%)

5.05 (0.27)

5.09 (0.31)

0.04 (0.23)

Total Cholesterol (mg/dL)

191.0 (35.6)

193.7 (38.3)

3.2 (29.3)

HDL-C (mg/dL)

56.5 (16.7)

56.5 (16.8)

0.1 (8.2)

LDL-C (mg/dL)

115.4 (32.0)

115.8 (33.2)

0.6 (24.1)

Triglycerides (mg/dL)

128.2 (80.1)

139.9 (116.6)

11.8 (90.2)

Prolactin (ng/mL)

10.529 (6.779)

10.040 (6.472)

−0.458 (7.002)

  1. HbA1c Hemoglobin A1c, HDL-C High-density lipoprotein-cholesterol, LDL-C Low-density lipoprotein-cholesterol